3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Endometrial Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Brain Neoplasms
3
Urogenital Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms, Unknown Primary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Pyloric Stenosis, Hypertrophic
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Ductal Adenocarcinoma
1
Neurofibromatosis 1
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lipodystrophy, Familial Partial
1
Leukemia, Myeloid, Acute
1
Interventions
pembrolizumab
155
Gemcitabine
139
Capecitabine
121
Paclitaxel
118
Fluorouracil
116
Oxaliplatin
110
Bevacizumab
104
Nivolumab
97
Leucovorin
97
Docetaxel
92
Cisplatin
89
Irinotecan
87
Carboplatin
84
Radiosurgery
83
Cyclophosphamide
70
Cetuximab
70
Magnetic Resonance Spectroscopy
68
Trastuzumab
56
Specimen Handling
56
Biopsy
56
Radiotherapy
55
Ipilimumab
52
Everolimus
48
Pemetrexed
46
Drug Therapy
45
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
43
Doxorubicin
41
Fulvestrant
38
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm Metastasis
×
Genetic Testing
×
Clear all
NCT01460186
2019-01-15
StoRM
Centre Leon Berard
Phase NA
Completed
1,000 enrolled